Henning Wege
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Hepatology 29
- Hepatocellular Carcinoma Treatment and Prognosis 24
- Liver physiology and pathology 7
-
- RNA Interference and Gene Delivery 5
- Co-authors
- Ansgar W. Lohse (20 shared papers)Björn Nashan (7 shared papers)Kornelius Schulze (13 shared papers)Mark Α. Zern (4 shared papers)Sabine Riethdorf (4 shared papers)Klaus Pantel (4 shared papers)Johann von Felden (14 shared papers)Tim H. Brümmendorf (6 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Oncotarget (4 papers)Journal of Hepatology (4 papers)BMC Cancer (4 papers)Cancers (2 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Henning Wege
59 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 98
- Hepatology 430
- Cancer Research 345
- Oncology 526
- Aging 22
- Immunology 219
Countries citing papers authored by Henning Wege
This map shows the geographic impact of Henning Wege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henning Wege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henning Wege more than expected).
Fields of papers citing papers by Henning Wege
This network shows the impact of papers produced by Henning Wege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henning Wege. The network helps show where Henning Wege may publish in the future.
Co-authors
The 25 scholars most cited alongside Henning Wege, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 203 | |
| 2 | 2002 | 174 | |
| 3 | 2015 | 150 | |
| 4 | 1991 | 149 | |
| 5 | 2003 | 134 | |
| 6 | 2004 | 112 | |
| 7 | 2016 | 75 | |
| 8 | 2017 | 66 | |
| 9 | 2009 | 56 | |
| 10 | 2016 | 51 | |
| 11 | 2001 | 44 | |
| 12 | 2003 | 40 | |
| 13 | 2021 | 35 | |
| 14 | 2014 | 31 | |
| 15 | 2019 | 29 | |
| 16 | 2014 | 27 | |
| 17 | 2009 | 26 | |
| 18 | 2010 | 25 | |
| 19 | 2017 | 23 | |
| 20 | 2021 | 19 |
About Henning Wege
Henning Wege is a scholar working on Hepatology, Molecular Biology, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 64 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Telomeres, Telomerase, and Senescence (10 papers), Liver physiology and pathology (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Mechanisms and Therapy (5 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Hepatology (430 citations), Cancer Research (345 citations), Oncology (526 citations), Aging (22 citations) and Immunology (219 citations). Henning Wege has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Ansgar W. Lohse, Björn Nashan, Kornelius Schulze, Mark Α. Zern, Sabine Riethdorf, Klaus Pantel, Johann von Felden, Tim H. Brümmendorf, Katharina Staufer and Christin Gasch. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Journal of Hepatology, BMC Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.